( 02105.hk)
市盈率-16.60市净率7.45市销率293.80股息率0.00%上市时间2023-06-29股价13.88港币 (4.36% , 2.71亿港币) 市值54.15亿港币总股本3.90亿上市至今年化投资收益率-5.85%港股通持仓占H股比例15.38%
所属三级行业生物技术 (恒生) 市盈率-49.59市净率2.75市销率5.16股息率0.63%
所属指数指数纳入纳出
备注 (0): 双击编辑备注
发表讨论

来凯医药-B(02105) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1鄒國強Independent Non Executive Director - A/F2023-06-16--
2LI MinIndependent Non Executive Director2023-06-16--
3YIN Xu DongIndependent Non Executive Director2023-06-16--
4GU Xiang Ju JustinExecutive Director2022-05-09--
5孫淵Non Executive Director2022-04-28--
6吉冬梅Non Executive Director2022-04-282023-09-29
7王國瑋Non Executive Director2019-07-01--
8XIE LingExecutive Director2018-05-11--
9LU Xiang Yang ChrisExecutive DirectorChairman2016-07-29--